Search
Stoke Therapeutics Inc
STOKAdd to Watchlist
29.320USD
+0.020+0.07%
Close 07-27 16:00（ET）Quotes delayed by 15 min
1.73BMarket Cap
LossP/E TTM
Stoke Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Stoke Therapeutics Inc is 8.30, ranking 149 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.25, which is -627.22% below the recent high of 54.03 and -3028.05% above the recent low of -320.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.